X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (58756) 58756
Book Review (6231) 6231
Publication (1624) 1624
Magazine Article (211) 211
Book Chapter (210) 210
Conference Proceeding (104) 104
Dissertation (44) 44
Book / eBook (26) 26
Newsletter (14) 14
Government Document (5) 5
Web Resource (5) 5
Newspaper Article (3) 3
Presentation (3) 3
Reference (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (51144) 51144
humans (44704) 44704
transplantation, autologous (44261) 44261
male (25488) 25488
female (24945) 24945
adult (19537) 19537
middle aged (17477) 17477
animals (13216) 13216
transplantation (9804) 9804
surgery (9177) 9177
aged (8796) 8796
adolescent (8464) 8464
abridged index medicus (8450) 8450
treatment outcome (8149) 8149
hematology (7610) 7610
skin transplantation (6239) 6239
follow-up studies (6123) 6123
oncology (5878) 5878
transplantation, homologous (5845) 5845
child (5398) 5398
methods (5311) 5311
time factors (4576) 4576
retrospective studies (4144) 4144
hematopoietic stem cell transplantation (3977) 3977
orthopedics (3862) 3862
dogs (3854) 3854
stem cells (3820) 3820
immunology (3810) 3810
bone marrow transplantation (3658) 3658
bone transplantation (3548) 3548
combined modality therapy (3161) 3161
child, preschool (3060) 3060
chemotherapy (3046) 3046
antineoplastic combined chemotherapy protocols - therapeutic use (2975) 2975
dentistry (2881) 2881
transplantation, autologous - methods (2788) 2788
young adult (2713) 2713
rats (2651) 2651
autologous transplantation (2627) 2627
care and treatment (2568) 2568
therapy (2425) 2425
prognosis (2297) 2297
postoperative complications (2283) 2283
stem cell transplantation (2260) 2260
recurrence (2093) 2093
prospective studies (2090) 2090
rabbits (2054) 2054
radiography (2005) 2005
autografts (1980) 1980
wound healing (1974) 1974
medicine & public health (1961) 1961
cancer (1891) 1891
bone-marrow transplantation (1873) 1873
research (1865) 1865
analysis (1843) 1843
knee (1832) 1832
high-dose chemotherapy (1829) 1829
graft survival (1809) 1809
bone-marrow-transplantation (1763) 1763
hematopoietic stem cells (1760) 1760
regeneration (1760) 1760
multiple myeloma - therapy (1748) 1748
health aspects (1711) 1711
hematopoietic stem cell transplantation - methods (1702) 1702
multiple myeloma (1663) 1663
disease-free survival (1648) 1648
infant (1641) 1641
medicine, research & experimental (1607) 1607
risk factors (1570) 1570
saphenous vein - transplantation (1570) 1570
cells, cultured (1564) 1564
survival (1557) 1557
mice (1539) 1539
bone transplantation - methods (1523) 1523
repair (1511) 1511
surgery, plastic (1436) 1436
bone marrow (1429) 1429
stem-cell transplantation (1418) 1418
survival rate (1418) 1418
cardiac & cardiovascular systems (1411) 1411
follow-up (1405) 1405
survival analysis (1403) 1403
autologous stem cell transplantation (1389) 1389
sport sciences (1354) 1354
colony-stimulating factor (1334) 1334
remission induction (1325) 1325
reconstruction (1279) 1279
veins - transplantation (1276) 1276
autologous chondrocyte implantation (1263) 1263
cell biology (1251) 1251
tissue engineering (1244) 1244
non-hodgkins-lymphoma (1236) 1236
kidney transplantation (1215) 1215
hematopoietic stem cell transplantation - adverse effects (1204) 1204
disease (1194) 1194
tendons - transplantation (1192) 1192
adipose tissue - transplantation (1191) 1191
aged, 80 and over (1189) 1189
medicine, general & internal (1165) 1165
cartilage (1152) 1152
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Scarborough Hospital - General (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46906) 46906
German (3122) 3122
French (2249) 2249
Russian (2155) 2155
Japanese (1039) 1039
Chinese (800) 800
Polish (550) 550
Italian (512) 512
Spanish (496) 496
Czech (280) 280
Portuguese (231) 231
Hungarian (144) 144
Dutch (99) 99
Romanian (74) 74
Turkish (66) 66
Croatian (62) 62
Slovak (61) 61
Danish (58) 58
Korean (53) 53
Norwegian (51) 51
Swedish (50) 50
Bulgarian (42) 42
Serbian (37) 37
Hebrew (31) 31
Ukrainian (31) 31
Finnish (17) 17
Bosnian (7) 7
Greek (7) 7
Slovenian (5) 5
Lithuanian (4) 4
Afrikaans (3) 3
Persian (2) 2
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer treatment and research, ISSN 0927-3042, 2019, Volume 176, pp. 269 - 287
Mature T-cell non-Hodgkin lymphomas (T-cell NHL) are a heterogeneous group of lymphoid malignancies including NK/T-cell lymphomas. Hematopoietic cell... 
NK/T-cell lymphoma | Graft-versus-lymphoma | Allogeneic hematopoietic cell transplantation | Autologous hematopoietic cell transplantation | Peripheral T-cell lymphoma | Cutaneous T-cell lymphoma
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 12, pp. 2039 - 2051
Abstract In contrast to the upfront setting in which the role of high-dose therapy with autologous hematopoietic cell transplantation (HCT) as consolidation of... 
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | Myeloma | Salvage therapy | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | COMBINATION THERAPY | LENALIDOMIDE PLUS DEXAMETHASONE | AUTOLOGOUS TRANSPLANTATION | FOLLOW-UP | RISK | IMMUNOLOGY | TRANSPLANTATION | ALLOGENEIC TRANSPLANTATION | MAINTENANCE | RANDOMIZED PHASE-III | HEMATOLOGY | LOW-DOSE DEXAMETHASONE | Myeloablative Agonists - therapeutic use | Recurrence | Humans | Antibodies, Monoclonal - therapeutic use | Multiple Myeloma - immunology | Transplantation, Autologous | Bone Marrow Transplantation - methods | Remission Induction | Proteasome Inhibitors - therapeutic use | Transplantation, Homologous | Randomized Controlled Trials as Topic | Multiple Myeloma - pathology | Multiple Myeloma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Salvage Therapy - methods | Immunologic Factors - therapeutic use | Relapse | Multiple myeloma | Bone marrow | Clinical trials | Transplantation | Conferences and conventions | Hematopoietic stem cells | Trade and professional associations | Diseases | Index Medicus | Clinical Medicine | Hematologi | Medical and Health Sciences | Hematology | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 874 - 885
Summary Background Relapsed multiple myeloma has no standard treatment, and the role of autologous stem-cell transplantation (ASCT) has not been fully defined.... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE | SUPERIORITY | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | IMPACT | METAANALYSIS | ONCOLOGY | CLINICAL-TRIALS | LENALIDOMIDE | SALVAGE THERAPY | INDUCTION | MARROW TRANSPLANTATION | Recurrence | Cyclophosphamide - administration & dosage | Peripheral Nervous System Diseases - chemically induced | Consolidation Chemotherapy - methods | Humans | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Multiple Myeloma - therapy | Time Factors | Adult | Female | Boronic Acids - administration & dosage | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Proportional Hazards Models | Thrombocytopenia - chemically induced | Disease Progression | Induction Chemotherapy - adverse effects | Retreatment | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged | Multiple Myeloma - genetics | Stem Cell Transplantation - adverse effects | Care and treatment | Relapse | Multiple myeloma | Clinical trials | Transplantation | Diseases | Cyclophosphamide | Chemotherapy | Hospitals | Stem cells | Dosage and administration | Product development | Cancer | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9808, pp. 1997 - 2004
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 1863 - 1869
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 14, pp. 1311 - 1320
In this trial, 700 patients with myeloma were randomly assigned to receive RVD therapy (lenalidomide, bortezomib, and dexamethasone) with or without autologous... 
DIAGNOSED MULTIPLE-MYELOMA | MEDICINE, GENERAL & INTERNAL | PHASE-III | AUTOLOGOUS TRANSPLANTATION | DARATUMUMAB MONOTHERAPY | INITIAL TREATMENT | FOLLOW-UP | PREDNISONE PLUS THALIDOMIDE | RANDOMIZED CONTROLLED-TRIAL | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Stem Cell Transplantation | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Adult | Female | Maintenance Chemotherapy | Thalidomide - adverse effects | Dexamethasone - administration & dosage | Lenalidomide | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Bortezomib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bortezomib - adverse effects | Aged | Usage | Care and treatment | Bortezomib | Dexamethasone | Patient outcomes | Multiple myeloma | Transplantation of organs, tissues, etc | Dosage and administration | Autografts | Gastrointestinal tract diseases | Minimal residual disease | Stem cell transplantation | Peripheral neuropathy | Patients | Chemotherapy | Melphalan | Thromboembolism | Neutropenia | Index Medicus | Abridged Index Medicus | Life Sciences | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 13, pp. 1195 - 1203
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 10/2017, Volume 23, Issue 10, pp. 1646 - 1650
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2012, Volume 30, Issue 25, pp. 3093 - 3099
Journal Article